Recruiting NA Vaping

New treatment option for Vaping

Official title Social Media Support Groups for Adolescent Vaping Cessation

ClinicalTrials.gov ID: NCT07540780

What this study is testing

What it's testing
The purpose of this study is to pilot test feasibility and acceptability of the Quit the Hit Toolkit, a social media-based nicotine vaping cessation program for adolescents and young adults, adapted for use in community settings.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 13 and older. Healthy volunteers may be eligible.

You may be able to join if

  • English literacy
  • Age between 13-21 years (group participants) or 18+ (coaches, peer mentors)
  • Indicate they use social media "most" (\>= 4) days per week (group participants)
  • Have vaped at least once per week in the past 30 days (90 percent of participants) (group participants)
  • Access to a computer or mobile phone with photo capability to verify abstinence from vaping (group participants)

You likely can't join if

  • No English literacy
  • Age under 13 or over 21 (group participants) or under 18 (coaches, peer mentors)
  • Insufficient social media use (3 or fewer days per week) (group participants)
  • Have not vaped at least once per week in past 30 days (group participants)
  • No access to computer or mobile phone with photo capability to verify abstinence from vaping (group participants)
  • Not considering or interested in quitting vaping in the next 30 days or 6 months (group participants)
See the full eligibility criteria
Who can join
  • English literacy
  • Age between 13-21 years (group participants) or 18+ (coaches, peer mentors)
  • Indicate they use social media "most" (\>= 4) days per week (group participants)
  • Have vaped at least once per week in the past 30 days (90 percent of participants) (group participants)
  • Access to a computer or mobile phone with photo capability to verify abstinence from vaping (group participants)
  • Indicate they are considering quitting or are interested in quitting with the next 6 months or within the next 30 days (group participants)
  • Currently reside in California, Minnesota, Oklahoma, or South Carolina
What rules you out
  • No English literacy
  • Age under 13 or over 21 (group participants) or under 18 (coaches, peer mentors)
  • Insufficient social media use (3 or fewer days per week) (group participants)
  • Have not vaped at least once per week in past 30 days (group participants)
  • No access to computer or mobile phone with photo capability to verify abstinence from vaping (group participants)
  • Not considering or interested in quitting vaping in the next 30 days or 6 months (group participants)
  • Not a resident of California, Minnesota, Oklahoma, or South Carolina

The study team makes the final eligibility decision.

Where it's taking place

  • San Francisco, California, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 13 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include San Francisco, California, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.